AGLagilon health, inc.
$82.66+185% 1Y
$82.66
$7.9152 weeks$129.35
AGL in its own filings
AGL's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
98
Events found in the filings · across 430 filings · the record starts in 2021
- Hard flags
- 1
Hard flags
- Most recent filing
- Aug 5, 2026
Most recent filing · Form 10-Q
- Record starts
- Jan 18, 2021
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 3, 2026
- Delisting notice / listing-rule failurepast_year
- 2025-11-07
- SEC comment-letter activity13 occurrences
- 2023-05-02
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 22, 2026On July 17, 2026, agilon health, inc. (the "Company") provided notice to Girish Venkatachaliah, the Company's Chief Technology Officer, that Mr. Venkatachaliah’s employment with the Company will terminate effective August 1, 2026 (the “Separation Date”)Director or officer change · Form 8-K
- Apr 27, 2026On April 24, 2026, agilon health, inc. (the “Company”) entered into an Employment Agreement (the “Employment Agreement”) with Tim O’Rourke, pursuant to which Mr. O’Rourke will serve as the Company’s Chief Executive Officer and President, reporting to the Board of Directors (the “Board”)Director or officer change · Form 8-K
- Mar 30, 2026To the extent required by.Shareholder rights modified · Form 8-K
- Mar 18, 2026On March 18, 2026, the Company issued a press release announcing the reverse stock split and that the Board approved the implementation of a reverse stock split of its Common Stock at a ratio of 1-for-25 (the "Reverse Stock Split")Shareholder vote results · Form 8-K
- Feb 25, 20264Q and YE 2025 Earnings Presentation February 2026 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.Earnings release · press release
- Feb 12, 2026On February 12, 2026 (the “Third Amendment Effective Date”), agilon health, inc. (the "Company"), agilon health management, inc.Material agreement entered · Form 8-K
- Jan 7, 2026Compensatory Arrangements of Certain Officers On December 31, 2025, agilon health, inc. (the “Company”) entered into an Amended and Restated Employment Agreement with Jeffrey Schwaneke, the Company’s Chief Financial Officer and Executive Vice President (the “Amended Employment Agreement”), effective as of January 1, 2026.Director or officer change · Form 8-K
- Nov 7, 2025On November 5, 2025, agilon health, inc.Delisting notice / listing-rule failure · Form 8-K
- Nov 4, 20253Q Earnings Presentation November 2025 Copyright © 2025 agilon health. Confidential internal document containing proprietary information. Do not distribute.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…